PRGO Share Price

Open 74.72 Change Price %
High 75.41 1 Day 0.63 0.84
Low 74.05 1 Week 2.14 2.93
Close 75.28 1 Month 5.33 7.62
Volume 1502678 1 Year -15.73 -17.28
52 Week High 99.14
52 Week Low 65.47
PRGO Important Levels
Resistance 2 76.54
Resistance 1 76.02
Pivot 74.91
Support 1 74.54
Support 2 74.02
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
DCTH 0.16 -33.33%
FTR 1.22 8.93%
FTR 1.22 8.93%
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
More..
NASDAQ USA Top Gainers Stocks
OPXAW 0.12 200.00%
AVEO 1.25 71.23%
LOCM 0.09 50.00%
MYRX 0.09 50.00%
SNCR 16.24 33.33%
QUIK 1.60 31.15%
WRES 0.09 28.57%
IIN 8.35 27.48%
IIN 8.35 27.48%
IIN 8.35 27.48%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
TOPS 0.80 -66.67%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Perrigo Company (NASDAQ: PRGO)

PRGO Technical Analysis 2
As on 23rd Jun 2017 PRGO Share Price closed @ 75.28 and we RECOMMEND Sell for LONG-TERM with Stoploss of 81.16 & Strong Buy for SHORT-TERM with Stoploss of 71.62 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRGO Target for June
1st Target up-side 78.09
2nd Target up-side 81.77
3rd Target up-side 85.44
1st Target down-side 67.61
2nd Target down-side 63.93
3rd Target down-side 60.26
PRGO Other Details
Segment EQ
Market Capital 10823602176.00
Sector Healthcare
Industry Drug Related Products
Offical website http://www.perrigo.com
PRGO Address
PRGO
Treasury Building
Lower Grand Canal Street
Dublin, 2
Ireland
Phone: 353 1 604 0031
Interactive Technical Analysis Chart Perrigo Company ( PRGO NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Perrigo Company
PRGO Business Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. Its businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia. In February 2013, it completed the acquisition of Leeds, United Kingdom-based Rosemont Pharmaceuticals Ltd. In April 2013, it closed the acquisition of Velcera, Inc. In June 2013, the Company acquired an ophthalmic sterile ointment and solution product portfolio from Fera Pharmaceuticals, LLC. In December 2013, it acquired Elan Corporation Plc.